Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Related structures:
AlphaFold database: E9ACM1
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 193 | 197 | PF00656 | 0.706 |
CLV_C14_Caspase3-7 | 35 | 39 | PF00656 | 0.741 |
CLV_NRD_NRD_1 | 277 | 279 | PF00675 | 0.743 |
CLV_NRD_NRD_1 | 54 | 56 | PF00675 | 0.725 |
CLV_NRD_NRD_1 | 88 | 90 | PF00675 | 0.499 |
CLV_PCSK_KEX2_1 | 277 | 279 | PF00082 | 0.742 |
CLV_PCSK_KEX2_1 | 54 | 56 | PF00082 | 0.724 |
CLV_PCSK_KEX2_1 | 87 | 89 | PF00082 | 0.529 |
CLV_PCSK_SKI1_1 | 10 | 14 | PF00082 | 0.694 |
CLV_PCSK_SKI1_1 | 248 | 252 | PF00082 | 0.375 |
CLV_Separin_Metazoa | 267 | 271 | PF03568 | 0.608 |
DEG_APCC_DBOX_1 | 86 | 94 | PF00400 | 0.483 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.681 |
DEG_SPOP_SBC_1 | 151 | 155 | PF00917 | 0.699 |
DEG_SPOP_SBC_1 | 186 | 190 | PF00917 | 0.705 |
DEG_SPOP_SBC_1 | 43 | 47 | PF00917 | 0.784 |
DOC_MAPK_gen_1 | 87 | 94 | PF00069 | 0.474 |
DOC_MAPK_MEF2A_6 | 209 | 218 | PF00069 | 0.449 |
DOC_MAPK_MEF2A_6 | 87 | 94 | PF00069 | 0.459 |
DOC_USP7_MATH_1 | 12 | 16 | PF00917 | 0.772 |
DOC_USP7_MATH_1 | 151 | 155 | PF00917 | 0.637 |
DOC_USP7_MATH_1 | 162 | 166 | PF00917 | 0.616 |
DOC_USP7_MATH_1 | 173 | 177 | PF00917 | 0.724 |
DOC_USP7_MATH_1 | 186 | 190 | PF00917 | 0.729 |
DOC_USP7_MATH_1 | 42 | 46 | PF00917 | 0.740 |
DOC_WW_Pin1_4 | 165 | 170 | PF00397 | 0.799 |
DOC_WW_Pin1_4 | 20 | 25 | PF00397 | 0.668 |
DOC_WW_Pin1_4 | 45 | 50 | PF00397 | 0.746 |
LIG_14-3-3_CanoR_1 | 114 | 122 | PF00244 | 0.508 |
LIG_14-3-3_CanoR_1 | 54 | 59 | PF00244 | 0.777 |
LIG_14-3-3_CanoR_1 | 7 | 16 | PF00244 | 0.647 |
LIG_BRCT_BRCA1_1 | 115 | 119 | PF00533 | 0.515 |
LIG_eIF4E_1 | 113 | 119 | PF01652 | 0.557 |
LIG_EVH1_1 | 76 | 80 | PF00568 | 0.756 |
LIG_FHA_1 | 11 | 17 | PF00498 | 0.707 |
LIG_FHA_1 | 113 | 119 | PF00498 | 0.567 |
LIG_FHA_1 | 231 | 237 | PF00498 | 0.617 |
LIG_FHA_1 | 258 | 264 | PF00498 | 0.639 |
LIG_FHA_2 | 105 | 111 | PF00498 | 0.589 |
LIG_FHA_2 | 166 | 172 | PF00498 | 0.763 |
LIG_Integrin_RGD_1 | 36 | 38 | PF01839 | 0.714 |
LIG_LIR_Gen_1 | 116 | 127 | PF02991 | 0.521 |
LIG_LIR_Nem_3 | 116 | 122 | PF02991 | 0.519 |
LIG_LIR_Nem_3 | 206 | 210 | PF02991 | 0.437 |
LIG_LIR_Nem_3 | 211 | 216 | PF02991 | 0.464 |
LIG_LIR_Nem_3 | 74 | 79 | PF02991 | 0.656 |
LIG_MYND_1 | 99 | 103 | PF01753 | 0.607 |
LIG_NRBOX | 264 | 270 | PF00104 | 0.633 |
LIG_PDZ_Class_1 | 311 | 316 | PF00595 | 0.532 |
LIG_SH2_STAT5 | 207 | 210 | PF00017 | 0.515 |
LIG_SH2_STAT5 | 241 | 244 | PF00017 | 0.540 |
LIG_SH2_STAT5 | 295 | 298 | PF00017 | 0.478 |
LIG_SH3_2 | 49 | 54 | PF14604 | 0.732 |
LIG_SH3_3 | 126 | 132 | PF00018 | 0.440 |
LIG_SH3_3 | 142 | 148 | PF00018 | 0.546 |
LIG_SH3_3 | 177 | 183 | PF00018 | 0.621 |
LIG_SH3_3 | 195 | 201 | PF00018 | 0.600 |
LIG_SH3_3 | 46 | 52 | PF00018 | 0.738 |
LIG_SH3_3 | 74 | 80 | PF00018 | 0.686 |
LIG_SUMO_SIM_anti_2 | 176 | 181 | PF11976 | 0.496 |
LIG_TRAF2_1 | 281 | 284 | PF00917 | 0.718 |
LIG_UBA3_1 | 268 | 275 | PF00899 | 0.477 |
LIG_WW_3 | 58 | 62 | PF00397 | 0.782 |
MOD_CDK_SPxK_1 | 20 | 26 | PF00069 | 0.564 |
MOD_CK1_1 | 154 | 160 | PF00069 | 0.639 |
MOD_CK1_1 | 165 | 171 | PF00069 | 0.565 |
MOD_CK1_1 | 187 | 193 | PF00069 | 0.665 |
MOD_CK1_1 | 45 | 51 | PF00069 | 0.748 |
MOD_CK1_1 | 53 | 59 | PF00069 | 0.735 |
MOD_CK2_1 | 250 | 256 | PF00069 | 0.583 |
MOD_CK2_1 | 29 | 35 | PF00069 | 0.566 |
MOD_Cter_Amidation | 275 | 278 | PF01082 | 0.738 |
MOD_GlcNHglycan | 115 | 118 | PF01048 | 0.517 |
MOD_GlcNHglycan | 154 | 157 | PF01048 | 0.617 |
MOD_GlcNHglycan | 160 | 163 | PF01048 | 0.669 |
MOD_GlcNHglycan | 313 | 316 | PF01048 | 0.591 |
MOD_GlcNHglycan | 56 | 59 | PF01048 | 0.755 |
MOD_GSK3_1 | 113 | 120 | PF00069 | 0.493 |
MOD_GSK3_1 | 150 | 157 | PF00069 | 0.589 |
MOD_GSK3_1 | 158 | 165 | PF00069 | 0.636 |
MOD_GSK3_1 | 184 | 191 | PF00069 | 0.620 |
MOD_GSK3_1 | 307 | 314 | PF00069 | 0.526 |
MOD_GSK3_1 | 43 | 50 | PF00069 | 0.711 |
MOD_GSK3_1 | 8 | 15 | PF00069 | 0.691 |
MOD_N-GLC_1 | 18 | 23 | PF02516 | 0.763 |
MOD_NEK2_1 | 150 | 155 | PF00069 | 0.663 |
MOD_NEK2_1 | 230 | 235 | PF00069 | 0.624 |
MOD_NEK2_1 | 250 | 255 | PF00069 | 0.539 |
MOD_NEK2_1 | 307 | 312 | PF00069 | 0.717 |
MOD_NEK2_2 | 5 | 10 | PF00069 | 0.554 |
MOD_PIKK_1 | 154 | 160 | PF00454 | 0.599 |
MOD_PK_1 | 259 | 265 | PF00069 | 0.647 |
MOD_PKA_1 | 54 | 60 | PF00069 | 0.773 |
MOD_PKA_2 | 113 | 119 | PF00069 | 0.447 |
MOD_PKA_2 | 230 | 236 | PF00069 | 0.618 |
MOD_PKA_2 | 53 | 59 | PF00069 | 0.721 |
MOD_Plk_1 | 18 | 24 | PF00069 | 0.775 |
MOD_Plk_1 | 29 | 35 | PF00069 | 0.649 |
MOD_ProDKin_1 | 165 | 171 | PF00069 | 0.797 |
MOD_ProDKin_1 | 20 | 26 | PF00069 | 0.670 |
MOD_ProDKin_1 | 45 | 51 | PF00069 | 0.746 |
MOD_SUMO_for_1 | 281 | 284 | PF00179 | 0.668 |
MOD_SUMO_rev_2 | 280 | 287 | PF00179 | 0.661 |
TRG_DiLeu_BaEn_1 | 264 | 269 | PF01217 | 0.661 |
TRG_DiLeu_BaLyEn_6 | 145 | 150 | PF01217 | 0.592 |
TRG_ENDOCYTIC_2 | 207 | 210 | PF00928 | 0.515 |
TRG_ENDOCYTIC_2 | 6 | 9 | PF00928 | 0.555 |
TRG_ER_diArg_1 | 86 | 89 | PF00400 | 0.536 |
TRG_Pf-PMV_PEXEL_1 | 225 | 229 | PF00026 | 0.577 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PCN8 | Leptomonas seymouri | 63% | 95% |
A0A1X0PA92 | Trypanosomatidae | 40% | 100% |
A0A3R7KEM6 | Trypanosoma rangeli | 42% | 100% |
A0A3S5H557 | Leishmania donovani | 91% | 100% |
A4HRW4 | Leishmania infantum | 91% | 100% |
C9ZKG9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 42% | 100% |
E9AJV9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 83% | 98% |
V5BC94 | Trypanosoma cruzi | 42% | 100% |